Dr Reddy’s climbs as drug maker launches Nexium’s generic
NEW DELHI: Shares of Dr Reddy’s Laboratories surged over 6 per cent in Monday’s trade after the drugmaker launched a generic version of Nexium following approval from the United States Food & Drug Administration (USFDA). Nexium is the world’s second most selling drug. It... read more »
Gold ETFs witness outflow of Rs 363cr in Apr-Aug FY 2016
NEW DELHI: Investors continue to pull out money from gold exchange-traded funds (ETFs), but the pace of outflow has slowed down in the current fiscal on account of the sluggish equity market trends. The Gold ETFs witnessed a net outflow of Rs 363 crore in the first five months (April-August) of... read more »
Will Alibaba crash impact Indian e-commerce valuation?
NEW DELHI: When Alibaba listed on NYSE a year ago, it created history with the highest share sale value, making the Chinese e-commerce giant valued at around $230 billion. A year on, the company might create history again but this time, for the wrong reasons. Its scrip has nosedived close to 40%... read more »
Pfizer to sell Thane plant to Vidhi Research for Rs 178 crore
Drug firm Pfizer has said it has entered into a business transfer agreement to sell its Thane plant as a going concern to Vidhi Research and Development LLP for Rs 178 crore. In a BSE filing, Pfizer said, “It has entered into a Business Transfer Agreement (BTA) for the transfer of the... read more »
